TWST:NSD-Twist Bioscience Corp (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 31.54

Change

0.00 (0.00)%

Market Cap

USD 1.62B

Volume

0.64M

Analyst Target

USD 75.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

N/A

USD 41.47B
ICLR ICON PLC

N/A

USD 25.49B
ILMN Illumina Inc

N/A

USD 19.47B
MEDP Medpace Holdings Inc

N/A

USD 12.27B
NTRA Natera Inc

N/A

USD 11.20B
EXAS EXACT Sciences Corporation

N/A

USD 10.68B
RDNT RadNet Inc

N/A

USD 3.57B
SHC Sotera Health Co

N/A

USD 3.10B
OLK Olink Holding AB ADR

N/A

USD 2.72B
NEOG Neogen Corporation

N/A

USD 2.63B

ETFs Containing TWST

EDOC:LSE Global X Telemedicine & D.. 4.99 % 0.00 %

N/A

USD 4.76M
WDNA:LSE WisdomTree BioRevolution .. 3.34 % 0.00 %

N/A

USD 2.81M
WBIO:LSE WisdomTree BioRevolution .. 3.20 % 0.00 %

N/A

USD 0.45M
WRNA:XETRA WisdomTree BioRevolution .. 3.05 % 0.00 %

N/A

USD 2.77M
CDNA:CA CI Bio-Revolution ETF 2.99 % 0.00 %

N/A

CAD 4.55M
WDNA 2.86 % 0.00 %

N/A

N/A
ARKG 0.00 % 0.75 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

USD 6.80B
FYX:LSE 0.00 % 0.00 %

N/A

N/A
IBBJ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.43% 52% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.43% 52% F 31% F
Trailing 12 Months  
Capital Gain 152.72% 98% N/A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 152.72% 98% N/A 97% N/A
Trailing 5 Years  
Capital Gain 13.70% 70% C- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.70% 70% C- 58% F
Average Annual (5 Year Horizon)  
Capital Gain 62.37% 88% B+ 93% A
Dividend Return 62.37% 88% B+ 92% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 173.17% 16% F 8% B-
Risk Adjusted Return 36.02% 82% B 70% C-
Market Capitalization 1.62B 75% C 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.